23-24 May 2022
Hybrid
Europe/Berlin timezone

Agenda

print version

Monday, May 23, 2022    

13:00–14:00

Lunch (optional)
and Registration

 

14:00–14:15

Welcome

Weichert /
von Bergwelt

14:15–14:45

Program MDEB Molecular Diagnostics, Early Detection and Biomarker Development

Heidegger / Westphalen

14:15–14:30

Microbial metabolites as biomarkers and therapeutics in stem cell transplantation

* Erik Thiele Orberg MD
Klinik und Poliklinik für Innere Medizin III, TranslaTUM, MRI

14:30–14:45

ctDNA profiling in B cell lymphomas

* Stefan Alig MD
Division of Oncology, Standford University, USA

14:45–15:45

Key Note
Prof. Joachim Schultze
Universität Bonn / DZNE
A vision for integrating AI and data sciences
into 21st century medicine

von Bergwelt

15:45–16:15

Coffee Break


 

16:15–16:45

Program EOM Exploitation of Oncogenic Mechanisms
part I Gastrointestinal Tumors

Saur

16:15–16:30

Deciperhing context-dependent fitness defects for precision
cancer therapy

Christian Braun MD
Dr von Haunersches Kinderspital, LMU Klinikum

16:30–16:45

Genomic NEC Landscapes for Patient-driven Disease and Vulnerability Modeling

* Joscha Griger PhD
Institute of Molecular Oncology and Functional Genomics, TranslaTUM, MRI

16:45–17:00


Networking AI Talk                                                                             Klauschen
 

16:45–17:00

Cancer AI for novel therapeutic and diagnostic approaches

Carsten Marr PhD
Institute of AI for Health, Helmholtz Munich

17:00–18:00

Cancer Core Structures                                                                     Algül /
in Munich                                                                                             Klauschen

17:00–17:15

SoO
DKTK School of Oncology

Sophie Dobiasch MD
Coordination SoO Munich; Klinik und Poliklinik für RadioOnkologie und Strahlentherapie, MRI

17:15–17:30

BZKF
Bayrisches Zentrum für Krebsforschung

Prof Claus Belka MD
Klinik und Poliklinik für Strahlentherapie und Radioonkologie, LMU Klinikum

17:30–18:00

Vision for Munich - Changes and Challenges in Oncology
CCCM - Comprehensive Cancer Center München

Prof Alexander M. M. Eggermont MD PhD
Clinical & Translational Immunotherapy, UMCU Utrecht University, Board CCCM

18:00 Dinner (optional)
 

 

 



Tuesday, May 24, 2022    

9:00–9:30 Platform CGP Cancer Genome and Proteome Analysis Platform Küster /
Greif
9:00–9:15 Robust Identification of Fusions in Tumor Transcriptomes: From AML to Solid Cancers

* Paul Kerbs PhD
ELLF, Medizinische Klinik und Poliklinik III, LMU Klinikum

9:15–9:30 Adding a proteomic component to molecular tumor boards - INFORM-MASTER-PRO * Julia Woortman MSc
Chair of Proteomics and Bioanalytics, TUM
9:30–10:15 Joint Funding Talks


Ruland
 

:30–10:00 CHOICE - Characterization of the osteo-hematopoietic niche
during malignant evolution

Prof Katharina Götze MD
Klinik und Poliklinik für Innere Medizin III, MRI

10:00–10:15 Immune responses in cancer patients with COVID-19 Andreas Moosman PhD
Medizinische Klinik und Poliklinik III, LMU Klinikum; Host Control of Viral Latency and Reactivation, DZIF Munich
10:15–10:30 SubPan/NEOLAP - Image-based subtyping of locally advanced pancreatic cancer Prof Rickmer Braren MD
Institut für Diagnostische Radiologie, MRI
10:30–10:45 Coffee Break
 
10:45–11:15 Program EOM Exploitation of Oncogenic Mechanisms
part II Haematologic Malignancies
Jeremias / Spiekermann
10:45–11:00 Adverse stem cell clones within a single patient's tumor predict clinical outcome in AML patients Binje Vick PhD
Research Unit Apoptosis in Hematopoietic Stem Cells, HMGU
11:00–11:15

OTUD6B is a dependency in multiple myeloma that drives S-phase entry via the RNA binding protein LIN28B

* Ria Spallek MSc
Klinik und Poliklinik für Innere Medizin III, TranslaTUM, MRI
11:15–12:15                                                   Key Note
                                  Prof. Carsten Müller-Tidow
                                 Universität Heidelberg / DKTK                           Jeremias     
                 Epigenomics, epitranscriptomics and novel therapy
                                          approaches in AML
12:15–12:30

Closing remarks and                                                                        von Bergwelt /
*Best Talk* Award                                                                             Weichert

  Lunch (optional)

 

  * Vote for Best Talk of a Young Scientist